58-22-0 98%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-19
Product Details
- Product NameTestosterone
- CAS No.58-22-0
- EINECS No.200-370-5
- MFC19H28O2
- MW288.43
- InChIKeyMUMGGOZAMZWBJJ-KRHBYBJCNA-N
- Appearancepowder
- storage temp. 2-8°C
- Melting point 152-156 °C
- Boiling point 370.65°C (rough estimate)
- density 1.0484 (rough estimate)
- Water Solubility 22.79mg/L(20 ºC)
Company Profile Introduction
Shakti Lifescience is a Shakti Group company, we are a successful & diversified pharma group with footprint in specialized API segments like Hormones, Steroids.
Shakti Lifescience was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company in the API segments of Hormones & Steroids which are the vital links of Human Body. Our business has a significant presence in markets, Local as well as Overseas regulated & Non-regulated markets.
Shakti Lifescience has gained loyalty of customers within India & abroad; products enjoy good response in the markets because of ‘high quality’ and ‘cost effective’ product range with ‘timely deliveries’.
Supplier other products
Recommended supplier
-
VIP1年
- Symbiotec Pharma Lab Pvt Ltd
- Testosterone 58-22-0 98%
- Inquiry
- 2024-03-13
-
VIP1年
- Brichem Life Sciences Pvt Ltd
- 58-22-0 98%
- Inquiry
- 2024-03-01
-
VIP1年
- Ralington Pharma
- 58-22-0 Testosterone 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Dy Mach Pharma
- Testosterone 58-22-0 98%
- Inquiry
- 2024-01-30
-
VIP1年
- Basil Drugs AND Pharmaceuticals Pvt Ltd
- Testosterone 98%
- Inquiry
- 2024-01-23
-
VIP1年
- Sun Pharmaceutical Industries Ltd
- 58-22-0 Testosterone 98%
- Inquiry
- 2024-01-09
-
VIP1年
- La Chandra Pharmalab Pvt. Ltd.
- Testosterone 58-22-0 98%
- Inquiry
- 2024-01-09
-
VIP1年
- Asg Biochem Pvt. Ltd
- Testosterone 98%
- Inquiry
- 2024-01-08
-
VIP1年
- Lupin Ltd
- 58-22-0 99%
- Inquiry
- 2024-01-05
- Since:2020-01-01
- Address: 10th Floor, 1004, Unique Towers, Off S V Road, Behind Patel Auto, Near Kamath Club, Goregaon, Mumbai
INQUIRY